Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 208201-208250 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT03339518
Breast Cancer Recurrence Risk Counseling
NA
Completed
173 participants
Started: Jul 25, 2011 · Completed: Dec 31, 2017
1 condition
2 sponsors
2 locations
NCT01911728
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
PHASE1
Completed
14 participants
Started: Jul 25, 2011 · Completed: Feb 21, 2012
2 conditions
2 sponsors
2 locations
NCT01402947
Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
PHASE1
Completed
30 participants
Started: Jul 25, 2011 · Completed: Aug 30, 2011
1 condition
1 sponsor
1 location
NCT01462617
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
PHASE1
Completed
61 participants
Started: Jul 24, 2011 · Completed: Mar 26, 2012
1 condition
1 sponsor
1 location
NCT01540851
Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial
NA
Completed
308 participants
Started: Jul 24, 2011 · Completed: May 10, 2014
2 conditions
1 sponsor
1 location
NCT01439438
Topiramate Bioequivalence Study Brazil - Fast
PHASE1
Completed
26 participants
Started: Jul 22, 2011 · Completed: Sep 11, 2011
1 condition
1 sponsor
1 location
NCT01394952
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
PHASE3
Completed
9,901 participants
Started: Jul 22, 2011 · Completed: Aug 21, 2018
2 conditions
1 sponsor
300 locations
NCT01402284
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
PHASE2
Completed
45 participants
Started: Jul 21, 2011 · Completed: Sep 24, 2020
1 condition
3 sponsors
1 location
NCT01414075
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
PHASE2
Completed
60 participants
Started: Jul 21, 2011 · Completed: Jan 10, 2013
2 conditions
2 sponsors
7 locations
NCT01333436
A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)
NA
Completed
93 participants
Started: Jul 20, 2011 · Completed: May 12, 2012
2 conditions
1 sponsor
1 location
NCT01400906
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
PHASE2
Completed
36 participants
Started: Jul 20, 2011 · Completed: Dec 12, 2012
1 condition
1 sponsor
2 locations
NCT01790243
LEVANT 2 Safety Registry
NA
Completed
1,189 participants
Started: Jul 20, 2011 · Completed: Nov 1, 2018
3 conditions
1 sponsor
8 locations
NCT01381692
Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma
PHASE1/PHASE2
Completed
9 participants
Started: Jul 20, 2011 · Completed: Sep 1, 2021
11 conditions
1 sponsor
11 locations
NCT01463891
Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)
N/A
Completed
963 participants
Started: Jul 19, 2011 · Completed: Nov 27, 2013
1 condition
1 sponsor
223 locations
NCT01408511
HPA Axis Study in Adults
PHASE2
Completed
23 participants
Started: Jul 19, 2011 · Completed: Dec 21, 2011
2 conditions
1 sponsor
3 locations
NCT01777035
Early Mobilization in the ICU
NA
Completed
200 participants
Started: Jul 19, 2011 · Completed: Jan 14, 2022
1 condition
1 sponsor
1 location
NCT01271504
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
PHASE1/PHASE2
Completed
102 participants
Started: Jul 19, 2011 · Completed: Jun 23, 2015
1 condition
2 sponsors
24 locations
NCT01403974
Phase I Trial of BI 836845 for Various Solid Cancer
PHASE1
Completed
61 participants
Started: Jul 19, 2011 · Completed: Dec 23, 2015
1 condition
1 sponsor
3 locations
NCT01352585
Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®
N/A
Completed
47 participants
Started: Jul 19, 2011 · Completed: Sep 19, 2013
1 condition
1 sponsor
10 locations
NCT01403025
Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
N/A
Completed
4,121 participants
Started: Jul 19, 2011 · Completed: Dec 28, 2015
2 conditions
1 sponsor
1 location
NCT01441037
Danazol for Genetic Bone Marrow and Lung Disorders
PHASE1/PHASE2
Completed
27 participants
Started: Jul 19, 2011 · Completed: Nov 14, 2016
1 condition
1 sponsor
1 location
NCT01342640
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
PHASE4
Completed
70 participants
Started: Jul 18, 2011 · Completed: Nov 30, 2012
1 condition
1 sponsor
5 locations
NCT01324180
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
PHASE1
Completed
14 participants
Started: Jul 18, 2011 · Completed: Jul 27, 2017
1 condition
2 sponsors
5 locations
NCT01411241
Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
PHASE3
Completed
720 participants
Started: Jul 18, 2011 · Completed: Apr 30, 2014
2 conditions
1 sponsor
4 locations
NCT01351935
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
PHASE1
Completed
113 participants
Started: Jul 18, 2011 · Completed: Jun 26, 2015
3 conditions
2 sponsors
13 locations
NCT01263704
A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia
PHASE2
Completed
42 participants
Started: Jul 17, 2011 · Completed: Apr 3, 2017
1 condition
1 sponsor
12 locations
NCT02429011
MRI Studies of Emotion in Depression
N/A
Completed
135 participants
Started: Jul 15, 2011 · Completed: May 31, 2016
1 condition
2 sponsors
1 location
NCT01401244
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
PHASE1
Completed
30 participants
Started: Jul 14, 2011 · Completed: Sep 27, 2011
5 conditions
1 sponsor
1 location
NCT04341324
Effect of ADT in Chinese Male With Prostate Cancer
N/A
Completed
60 participants
Started: Jul 14, 2011 · Completed: Dec 4, 2019
1 condition
1 sponsor
0 locations
NCT01468155
DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation
PHASE4
Completed
50 participants
Started: Jul 13, 2011 · Completed: Jun 7, 2017
1 condition
2 sponsors
1 location
NCT01449799
An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers
PHASE1
Completed
24 participants
Started: Jul 13, 2011 · Completed: Sep 21, 2011
1 condition
1 sponsor
1 location
NCT01376323
A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
PHASE2
Completed
92 participants
Started: Jul 13, 2011 · Completed: Sep 17, 2012
1 condition
1 sponsor
15 locations
NCT05859802
Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis
PHASE2/PHASE3
Completed
35 participants
Started: Jul 13, 2011 · Completed: Jan 9, 2016
1 condition
3 sponsors
0 locations
NCT01266031
Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PHASE1/PHASE2
Completed
96 participants
Started: Jul 12, 2011 · Completed: Jan 31, 2017
2 conditions
20 sponsors
1 location
NCT01363128
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
PHASE2
Completed
72 participants
Started: Jul 12, 2011 · Completed: Apr 8, 2020
7 conditions
2 sponsors
1 location
NCT03109678
A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™
NA
Completed
80 participants
Started: Jul 12, 2011 · Completed: Mar 7, 2012
3 conditions
2 sponsors
0 locations
NCT03343106
Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement
NA
Completed
58 participants
Started: Jul 12, 2011 · Completed: Jan 9, 2017
1 condition
3 sponsors
2 locations
NCT03666338
Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization
NA
Completed
200 participants
Started: Jul 11, 2011 · Completed: Feb 4, 2016
2 conditions
4 sponsors
0 locations
NCT01513187
Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
PHASE1/PHASE2
Completed
53 participants
Started: Jul 11, 2011 · Completed: Feb 22, 2019
1 condition
2 sponsors
13 locations
NCT01362374
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
PHASE1
Completed
122 participants
Started: Jul 11, 2011 · Completed: Oct 16, 2020
1 condition
1 sponsor
11 locations
NCT01409135
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
PHASE1
Completed
34 participants
Started: Jul 11, 2011 · Completed: Apr 27, 2015
3 conditions
3 sponsors
9 locations
NCT01490489
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
NA
Completed
142 participants
Started: Jul 11, 2011 · Completed: Mar 13, 2015
2 conditions
1 sponsor
1 location
NCT01449903
Survival of Different Core Build-up Materials
N/A
Completed
300 participants
Started: Jul 11, 2011 · Completed: Dec 19, 2017
1 condition
1 sponsor
1 location
NCT03203720
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder
NA
Completed
45 participants
Started: Jul 11, 2011 · Completed: Dec 30, 2014
2 conditions
1 sponsor
1 location
NCT04578496
A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
PHASE3
Completed
16 participants
Started: Jul 11, 2011 · Completed: Feb 27, 2014
1 condition
1 sponsor
0 locations
NCT01359696
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
PHASE1
Completed
40 participants
Started: Jul 11, 2011 · Completed: May 29, 2014
1 condition
1 sponsor
3 locations
NCT01440335
Initial Study of Fenoterol as a Treatment for Heart Failure
PHASE1
Completed
29 participants
Started: Jul 10, 2011 · Completed: Apr 15, 2014
1 condition
1 sponsor
1 location
NCT01337765
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
PHASE1
Completed
29 participants
Started: Jul 8, 2011 · Completed: Mar 22, 2013
2 conditions
1 sponsor
6 locations
NCT01392209
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PHASE1
Completed
15 participants
Started: Jul 8, 2011 · Completed: Nov 15, 2019
8 conditions
4 sponsors
5 locations
NCT01667432
An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B
N/A
Completed
141 participants
Started: Jul 8, 2011 · Completed: Aug 12, 2014
1 condition
1 sponsor
9 locations
Previous
1
More pages
4162
4163
4164
4165
4166
4167
4168
More pages
6093
Next